Skip to main content
. 2021 Jul 20;38(6):747–756. doi: 10.1007/s10719-021-10003-1

Fig. 1.

Fig. 1

Workflow for semi-automated, high throughput reductive β-elimination, coupled to ultrahigh resolution MALDI-FT-ICR MS for O-glycosylation analysis of in vitro established cell lines